Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldesleukin and ciclosporin in immune system diseases
2020-005068-70Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2020
- Modality
- Small Molecules, Peptides, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of aldesleukin and cyclosporine in Immune disorder, sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2020; status: active.
02
Drugs
aldesleukincyclosporine
03
Conditions
Immune disorder
Beyond the preview
Go deeper on 2020-005068-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005068-70.